Evaluation of the Suitability of Biocompatible Carriers as Artificial Transplants Using Cultured Porcine Corneal Endothelial Cells.


Journal

Current eye research
ISSN: 1460-2202
Titre abrégé: Curr Eye Res
Pays: England
ID NLM: 8104312

Informations de publication

Date de publication:
03 2019
Historique:
pubmed: 20 10 2018
medline: 2 5 2020
entrez: 20 10 2018
Statut: ppublish

Résumé

Purpose/Aim: Evaluating the suitability of bioengineered collagen sheets and human anterior lens capsules (HALCs) as carriers for cultivated porcine corneal endothelial cells (pCECs) and in vitro assessment of the cell-carrier sheets as tissue-engineered grafts for Descemet membrane endothelial keratoplasty (DMEK). pCECs were isolated, cultured up to P2 and seeded onto LinkCell™ bioengineered matrices of 20 µm (LK20) or 100 µm (LK100) thickness, and on HALC. During expansion, pCEC viability and morphology were assessed by light microscopy. ZO-1 and Na During in vitro expansion, cultured pCECs retained their proliferative capacity, as shown by the positive staining for proliferative marker Ki67, and a high cell viability rate (96 ± 5%). pCECs seeded on all carriers formed a monolayer of hexagonal, tightly packed cells that expressed ZO-1 and Na In vitro DMEK surgery showed HALC as the most suitable carrier for cultivated pCECs with good intraoperative graft handling. LK20 carrier showed good biocompatibility, but required a DSEK-adapted surgical protocol. Both carriers might be notional candidates for potential future clinical applications.

Identifiants

pubmed: 30339045
doi: 10.1080/02713683.2018.1536215
doi:

Substances chimiques

Biocompatible Materials 0
Ki-67 Antigen 0
Zonula Occludens-1 Protein 0
Collagen 9007-34-5
Sodium-Potassium-Exchanging ATPase EC 7.2.2.13

Types de publication

Evaluation Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

243-249

Auteurs

Daniele Spinozzi (D)

a Netherlands Institute for Innovative Ocular Surgery , Rotterdam , The Netherlands.

Alina Miron (A)

a Netherlands Institute for Innovative Ocular Surgery , Rotterdam , The Netherlands.

Marieke Bruinsma (M)

a Netherlands Institute for Innovative Ocular Surgery , Rotterdam , The Netherlands.

Isabel Dapena (I)

a Netherlands Institute for Innovative Ocular Surgery , Rotterdam , The Netherlands.
b Melles Cornea Clinic Rotterdam , Rotterdam , The Netherlands.

Itay Lavy (I)

a Netherlands Institute for Innovative Ocular Surgery , Rotterdam , The Netherlands.
b Melles Cornea Clinic Rotterdam , Rotterdam , The Netherlands.

Perry S Binder (PS)

c Gavin Herbert Eye Institute , University of California , Irvine , California , USA.

Mehrdad Rafat (M)

d LinkoCare Life Science AB , Linköping , Sweden.
e Department of Biomedical Engineering , Linköping University , Linköping , Sweden.

Silke Oellerich (S)

a Netherlands Institute for Innovative Ocular Surgery , Rotterdam , The Netherlands.

Gerrit R J Melles (GRJ)

a Netherlands Institute for Innovative Ocular Surgery , Rotterdam , The Netherlands.
b Melles Cornea Clinic Rotterdam , Rotterdam , The Netherlands.
f Amnitrans EyeBank Rotterdam , Rotterdam , The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH